{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:12:23Z","timestamp":1761520343706,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clcc.2020.12.001","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T22:17:36Z","timestamp":1608243456000},"page":"e139-e149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8882-2348","authenticated-orcid":false,"given":"Benjamin E.","family":"Ueberroth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex J.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8674-8102","authenticated-orcid":false,"given":"Jason S.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Hobday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Ashman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanios S.","family":"Bekaii-Saab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorvardur R.","family":"Halfdanarson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Bassam","family":"Sonbol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2020.12.001_bib1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/MPA.0b013e3181ebb56f","article-title":"The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas","volume":"39","author":"Strosberg","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.clcc.2020.12.001_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000493318","article-title":"Unmet needs in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3)","volume":"108","author":"Sorbye","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.clcc.2020.12.001_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ecl.2018.05.001","article-title":"The problem of high-grade gastroenteropancreatic neuroendocrine neoplasms: well-differentiated neuroendocrine tumors, neuroendocrine carcinomas, and beyond","volume":"47","author":"Sorbye","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.clcc.2020.12.001_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10350-003-0038-1","article-title":"Neuroendocrine carcinomas of the colon and rectum","volume":"47","author":"Bernick","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2020.12.001_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.seminoncol.2012.11.011","article-title":"The management of extrapulmonary poorly differentiated (high-grade) neuroendocrine carcinomas","volume":"40","author":"Smith","year":"2013","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clcc.2020.12.001_bib6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/cncr.31124","article-title":"Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: a SEER database analysis of 162,983 cases","volume":"124","author":"Dasari","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2020.12.001_bib7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5946\/ce.2017.134","article-title":"Diagnosis and management of rectal neuroendocrine tumors","volume":"50","author":"Chablaney","year":"2017","journal-title":"Clin Endosc"},{"key":"10.1016\/j.clcc.2020.12.001_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jjco\/hyl009","article-title":"T1 neuroendocrine carcinoma of anal canal after transanal resection for intramucosal adenocarcinoma","volume":"36","author":"Kobayashi","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clcc.2020.12.001_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02482243","article-title":"The effectiveness of chemotherapy with cisplatin and 5-fluorouracil for recurrent small cell neuroendocrine carcinoma of the rectum: report of a case","volume":"29","author":"Okuyama","year":"1999","journal-title":"Surg Today"},{"key":"10.1016\/j.clcc.2020.12.001_bib10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/COC.0000000000000211","article-title":"Chemoradiation for high-grade neuroendocrine carcinoma of the rectum and anal canal","volume":"40","author":"Voong","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clcc.2020.12.001_bib11","first-page":"19960","author":"Bruera","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2020.12.001_bib12","first-page":"2245","article-title":"[A case of small cell undifferentiated carcinoma (SCUC) of the rectum treated with etoposide, cis-platinum and radiotherapy]","volume":"19","author":"Sato","year":"1992","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.clcc.2020.12.001_bib13","first-page":"3","article-title":"Long term outcomes of neuroendocrine carcinomas (high-grade neuroendocrine tumors) of the colon, rectum, and anal canal","volume":"151","author":"Aytac","year":"2014","journal-title":"J\u00a0Visc Surg"},{"key":"10.1016\/j.clcc.2020.12.001_bib14","first-page":"386379","article-title":"Large cell neuroendocrine carcinoma of the rectum presenting with extensive metastatic disease","volume":"2014","author":"Minocha","year":"2014","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.clcc.2020.12.001_bib15","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.12998\/wjcc.v7.i14.1865","article-title":"Colorectal neuroendocrine carcinoma: a case report and review of the literature","volume":"7","author":"Yoshida","year":"2019","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.clcc.2020.12.001_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.coc.0000239171.73849.48","article-title":"An unusual case of small cell carcinoma of the anal canal","volume":"32","author":"Khan","year":"2009","journal-title":"Am J Clin Oncol"},{"issue":"15 Suppl","key":"10.1016\/j.clcc.2020.12.001_bib17","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1200\/JCO.2016.34.15_suppl.4020","article-title":"Genomic profiling to distinguish poorly differentiated neuroendocrine carcinomas arising in different sites","volume":"34","author":"Bergsland","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2020.12.001_bib18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.6004\/jnccn.2018.0061","article-title":"Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"Benson","year":"2018","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clcc.2020.12.001_bib19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/annonc\/mds276","article-title":"Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study","volume":"24","author":"Sorbye","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2020.12.001_bib20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1470-2045(19)30798-3","article-title":"Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial","volume":"21","author":"Bridgewater","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2020.12.001_bib21","article-title":"Pre- and postoperative capecitabine without or with oxaliplatin in locally advanced rectal cancer: PETACC 6 trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD","author":"Schmoll","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2020.12.001_bib22","article-title":"Adjuvant chemotherapy versus observation following resection for patients with nonmetastatic poorly differentiated colorectal neuroendocrine carcinomas","author":"Mao","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2020.12.001_bib23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1245\/s10434-020-08730-0","article-title":"Impact of postoperative chemotherapy on the survival of patients with high-grade gastroenteropancreatic neuroendocrine carcinoma","volume":"28","author":"Schmitz","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2020.12.001_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000502825","article-title":"Chemotherapy in resected neuroendocrine carcinomas of the digestive tract: a national study from the French Group of Endocrine Tumours","volume":"110","author":"Pellat","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.clcc.2020.12.001_bib25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.6004\/jnccn.2017.0050","article-title":"Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"Ettinger","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clcc.2020.12.001_bib26","doi-asserted-by":"crossref","first-page":"e1864","DOI":"10.1097\/MD.0000000000001864","article-title":"Radiochemotherapy versus surgery in nonmetastatic anorectal neuroendocrine carcinoma: a multicenter study by the Association des Gastro-Enterologues Oncologues","volume":"94","author":"Brieau","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clcc.2020.12.001_bib27","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/cncr.32750","article-title":"Etoposide and cisplatin versus irinotecan and cisplatin as the first-line therapy for patients with advanced, poorly differentiated gastroenteropancreatic neuroendocrine carcinoma: a randomized phase 2 study","volume":"126","author":"Zhang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2020.12.001_bib28","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2020.12.001_bib29","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus\u00a0platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2020.12.001_bib30","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1158\/1078-0432.CCR-20-0790","article-title":"Ipilimumab and nivolumab in rare tumors S1609: neuroendocrine-response","volume":"26","author":"Patel","year":"2020","journal-title":"Clin Cancer Res"},{"year":"2020","author":"Gile","series-title":"Efficacy of checkpoint inhibitors in neuroendocrine neoplasms: the Mayo Clinic Experience. NANETS 2020 Symposium Abstracts","key":"10.1016\/j.clcc.2020.12.001_bib31"},{"key":"10.1016\/j.clcc.2020.12.001_bib32","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41416-020-0775-0","article-title":"Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials","volume":"122","author":"Vijayvergia","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2020.12.001_bib33","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1158\/1078-0432.CCR-20-1804","article-title":"Comprehensive genomic profiling of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs)","volume":"26","author":"Puccini","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2020.12.001_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jso.24834","article-title":"Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma","volume":"117","author":"Idrees","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.clcc.2020.12.001_bib35","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/ijc.31828","article-title":"BRAF(V600E) mutation: a promising target in colorectal neuroendocrine carcinoma","volume":"144","author":"Dizdar","year":"2019","journal-title":"Int J Cancer"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002820301699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002820301699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:07:31Z","timestamp":1761520051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002820301699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1533002820301699"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2020.12.001","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2020.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}